The therapeutic biomarkers of IL-1α, IL-1β, IL-6, IL-37, TNF-α, NK-kB, TGF-β1, CD14, CD571, and metabolites were summarized in various ALDs. This evidence concerns the gene TNF and albinism-hearing loss syndrome.